794 results on '"Swanstrom, Ronald"'
Search Results
52. A fitness bottleneck in HIV-1 transmission: A successful infection is determined in part by how close a viral genome is to an ideal sequence
53. HIV-1 Sequence Diversity as a Window Into HIV-1 Biology
54. Combined noncanonical NF-κB agonism and targeted BET bromodomain inhibition reverse HIV latency ex vivo
55. Infection and inflammation: New perspectives on Alzheimer's disease
56. Integrating the HIV-1 assembly/maturation pathway
57. Quantification of the Latent HIV-1 Reservoir Using Ultra Deep Sequencing and Primer ID in a Viral Outgrowth Assay
58. Treatment as Prevention: Characterization of Partner Infections in the HIV Prevention Trials Network 052 Trial
59. Selection of HIV-1 for resistance to fifthgeneration protease inhibitors reveals two independent pathways to highlevel resistance.
60. Compartmentalization, Viral Evolution, and Viral Latency of HIV in the CNS
61. HIV-1 target cells in the CNS
62. CAPRISA 004 Tenofovir Microbicide Trial: No Impact of Tenofovir Gel on the HIV Transmission Bottleneck
63. Context Surrounding Processing Sites Is Crucial in Determining Cleavage Rate of a Subset of Processing Sites in HIV-1 Gag and Gag-Pro-Pol Polyprotein Precursors by Viral Protease
64. Lethal mutagenesis as an antiviral strategy
65. HIV Reservoirs in the Central Nervous System
66. Accurate sampling and deep sequencing of the HIV-1 protease gene using a Primer ID
67. The Regulation of Sequential Processing of HIV-1 Gag by the Viral Protease
68. A Substantial Transmission Bottleneck among Newly and Recently HIV-1–Infected Injection Drug Users in St Petersburg, Russia
69. Identification and Characterization of Transmitted and Early Founder Virus Envelopes in Primary HIV-1 Infection
70. Dynamics of Simian Immunodeficiency Virus Populations in Blood and Cerebrospinal Fluid over the Full Course of Infection
71. Stephan Oroszlan and the Proteolytic Processing of Retroviral Proteins: Following A Pro
72. The Triple Threat of HIV-1 Protease Inhibitors
73. Weighted Phenotypic Susceptibility Scores Are Predictive of the HIV-1 RNA Response in Protease Inhibitor-Experienced HIV-1-Infected Subjects
74. Durability of Response to Treatment among Antiretroviral-Experienced Subjects: 48-Week Results from AIDS Clinical Trials Group Protocol 359
75. Reply to Troth et al
76. Randomized Study of Saquinavir with Ritonavir or Nelfinavir Together with Delavirdine, Adefovir, or Both in Human Immunodeficiency Virus-Infected Adults with Virologic Failure on Indinavir: AIDS Clinical Trials Group Study 359
77. Selection of Multiple Human Immunodeficiency Virus Type 1 Variants that Encode Viral Proteases with Decreased Sensitivity to an Inhibitor of the Viral Protease
78. Human Immunodeficiency Virus Type 1 Gag Proteins are Processed in Two Cellular Compartments
79. Transduction of a Cellular Oncogene: The Genesis of Rous Sarcoma Virus
80. Nucleotide Sequence of Cloned Unintegrated Avian Sarcoma Virus DNA: Viral DNA Contains Direct and Inverted Repeats Similar to Those in Transposable Elements
81. Expression and Processing of the AIDS Virus Reverse Transcriptase in Escherichia coli
82. Vertical T cell immunodominance and epitope entropy determine HIV-1 escape
83. Evolution of an HIV glycan-dependent broadly neutralizing antibody epitope through immune escape
84. Immunological Correlates of the HIV-1 Replication-Competent Reservoir Size
85. Epitranscriptomic addition of m6A regulates HIV-1 RNA stability and alternative splicing
86. β-d-N4-hydroxycytidine Inhibits SARS-CoV-2 Through Lethal Mutagenesis But Is Also Mutagenic To Mammalian Cells
87. The HIV-1 Env Protein: A Coat of Many Colors
88. HIV/AIDS: A fitness bottleneck in HIV-1 transmission
89. Architecture and secondary structure of an entire HIV-1 RNA genome
90. HIV-1: To Splice or Not to Splice, That Is the Question
91. HIV- 1: To Splice Or Not To Splice, That Is THE Question
92. Primer ID Next-Generation Sequencing for the Analysis of a Broad Spectrum Antiviral Induced Transition Mutations and Errors Rates in a Coronavirus Genome
93. The HIV-1 latent reservoir is largely sensitive to circulating T cells
94. Viral Protease Inhibitors
95. Two Genetic Differences between Closely Related Zika Virus Strains Determine Pathogenic Outcome in Mice
96. Author response: The HIV-1 latent reservoir is largely sensitive to circulating T cells
97. A living WHO guideline on drugs for covid-19
98. Fact and Fiction about 1%: Next Generation Sequencing and the Detection of Minor Drug Resistant Variants in HIV-1 Populations with and without Unique Molecular Identifiers
99. Acetylation of Cytidine Residues Boosts HIV-1 Gene Expression by Increasing Viral RNA Stability
100. Structural Analysis of Potent Hybrid HIV-1 Protease Inhibitors Containing Bis-tetrahydrofuran in a Pseudosymmetric Dipeptide Isostere
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.